- Home
- ODFL vs TAK Comparison
ODFL vs TAK Comparison
Compare ODFL & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ODFL | TAK |
|---|---|---|
| Founded | 1934 | 1781 |
| Country | United States | Japan |
| Employees | 20591 | 47455 |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.8B | 52.4B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | ODFL | TAK |
|---|---|---|
| Price | $209.90 | $16.22 |
| Analyst Decision | Buy | |
| Analyst Count | 21 | 0 |
| Target Price | ★ $190.15 | N/A |
| AVG Volume (30 Days) | 1.9M | ★ 2.8M |
| Earning Date | 04-29-2026 | 05-13-2026 |
| Dividend Yield | 0.55% | ★ 3.24% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.14 | N/A |
| Revenue | ★ $5,496,389,000.00 | N/A |
| Revenue This Year | $4.41 | $0.16 |
| Revenue Next Year | $9.04 | $1.22 |
| P/E Ratio | $181.75 | ★ $41.25 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $126.01 | $12.99 |
| 52 Week High | $233.79 | $18.90 |
Technical Indicators
Market Signals| Indicator | ODFL | TAK |
|---|---|---|
| Relative Strength Index (RSI) | 56.28 | 33.79 |
| Support Level | $187.36 | $15.88 |
| Resistance Level | $221.63 | $16.48 |
| Average True Range (ATR) | 6.80 | 0.24 |
| MACD | 1.05 | 0.03 |
| Stochastic Oscillator | 96.32 | 25.00 |
Price Performance
Historical ComparisonAbout ODFL Old Dominion Freight Line Inc.
Old Dominion Freight Line is the second-largest less-than-truckload carrier in the United States (following FedEx Freight), with roughly 260 service centers and 11,000-plus tractors. It is one of the most disciplined and efficient providers in the trucking industry, and its profitability and capital returns are well above those of its peers. Strategic initiatives focus on increasing network density through market-share gains and on maintaining industry-leading service (including ultralow cargo claims) through steadfast infrastructure investment.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.